# 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

> **NCT00946985** · PHASE4 · TERMINATED · sponsor: **Ortho-McNeil Janssen Scientific Affairs, LLC** · enrollment: 163 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** paliperidone palmitate
- **DRUG:** oral risperidone

## Key facts

- **NCT ID:** NCT00946985
- **Lead sponsor:** Ortho-McNeil Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 163 (ACTUAL)
- **Why stopped:** The recruitment rate for the study was inadequate to achieve its enrollment goals.
- **Last updated:** 2012-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946985, "28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00946985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*